A Study of Navenibart in Participants With Hereditary Angioedema

Clinical trial NCT06842823 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06842823
Sponsor: Astria Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2025-03-20
Primary completion: 2026-12-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.